# Wockhardt Limited, Aurangabad, India – FDA Inspections

Source: https://www.keypedia.com/companies/wockhardt-limited/ccc61a51-f48a-42ca-a0c8-e1834295fd3f

> Inspection records and compliance data for Wockhardt Limited in Aurangabad. 6 FDA inspections on record (2 OAI), last inspected April 24, 2026.

---

## Details

- Name: Wockhardt Limited
- FEI Number: 3002808503
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: L-1, MIDC Area, Jalgaon Road 43, Chikalthana
- City: Aurangabad
- Country Name: India
- Address: L-1, MIDC Area, Jalgaon Road 43, Chikalthana, Aurangabad, India
- Country: India

## Related Documents

- FDA Inspection 1319878 - Wockhardt Limited - 2026-04-24 — source: FDA, date: April 24, 2026
- FDA Inspection 1097975 - Wockhardt Limited - 2019-06-12 — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2019
- FDA Inspection 1089444 - Wockhardt Limited - 2019-04-12 — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2019
- [FDA Inspection 921885 - Wockhardt Limited - 2015-03-17](https://www.keypedia.com/records/fda_inspections/wockhardt-limited/7869cbd3-0a7d-4313-b23d-2ba16b431a3e) — classification: Official Action Indicated (OAI), source: FDA, date: March 17, 2015
- [EMA GMP - Wockhardt Limited - UK API 8913 Insp GMP 8913/18322-0006 - NCR - 2015-01-16](https://www.keypedia.com/records/ema/wockhardt-limited/d47c5856-adc5-4a13-89c6-efa32bf72620) — source: EMA, date: January 16, 2015
- [FDA Inspection 844314 - Wockhardt Limited - 2013-07-31](https://www.keypedia.com/records/fda_inspections/wockhardt-limited/c94173ce-cf5b-4102-897b-f285b7c151c3) — classification: Official Action Indicated (OAI), source: FDA, date: July 31, 2013
- [EMA GMP - Wockhardt Limited - Insp GMP 8913/41464-0006 - NCR - 2013-07-02](https://www.keypedia.com/records/ema/wockhardt-limited/8665598e-9b81-44d2-85b0-be1ce1fddffd) — source: EMA, date: July 2, 2013
- FDA Inspection 703178 - Wockhardt Limited - 2010-12-17 — classification: No Action Indicated (NAI), source: FDA, date: December 17, 2010

## Related Companies

- [Chifeng Arker Pharmaceutical Technology Co., Ltd.](https://www.keypedia.com/companies/chifeng-arker-pharmaceutical-technology-co-ltd/8d2fd1e4-d884-42a9-b755-ed2525b0bde3)
- [Legacy Pharmaceuticals Switzerland GmbH](https://www.keypedia.com/companies/legacy-pharmaceuticals-switzerland-gmbh/12fbec96-87c8-4cc5-9c5d-f13acd0766f8)
- [CSPC Innovation Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/cspc-innovation-pharmaceutical-co-ltd/9d3d38db-70ec-41a6-b7da-1227ed2fdad7)
- [Actelion Pharmaceuticals Ltd.](https://www.keypedia.com/companies/actelion-pharmaceuticals-ltd/6a69a862-a86e-4585-a629-480925833294)
- [Purdue Pharma L.P.](https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346)
- [Pfizer, Inc.](https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff)
- [Neos Therapeutics, LP](https://www.keypedia.com/companies/neos-therapeutics-lp/b0c09540-d002-4817-8f57-7903d10d044f)
- [FAR Specialty Products, Inc.](https://www.keypedia.com/companies/far-specialty-products-inc/4c72d071-0e94-4e7b-b968-b1aca96ea5e0)
- [Chartwell Pharmaceuticals Amityville, LLC](https://www.keypedia.com/companies/chartwell-pharmaceuticals-amityville-llc/d8360380-d99c-4c6b-a098-04d0bcc0f7c1)
- [Sanofi US Services, Inc.](https://www.keypedia.com/companies/sanofi-us-services-inc/f353cbc0-ab3f-4c16-86a1-b9ee2af4e4a1)